✦ LIBER ✦

164 Primary therapy of ovarian cancer with paclitaxel/carboplatin/gemcitabine (TCG): a phase II study (ovar-8 protocol)

✍ Scribed by A.K. Belau; U. Wagner; J. Pfisterer; B. Richter; A. Stähle; C. Jackisch; H.J. Lück; W. Schröder; S. Olbricht; A. du Bois

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of paclitaxel, carbopla

✍ A. du Bois; A. Belau; U. Wagner; J. Pfisterer; B. Schmalfeldt; B. Richter; A. St 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Paclitaxel-carboplatin-gemcitabine (TCG)

✍ A. du BOIS; J. SEHOULI; B. LUND; F. JOLY; J. HUOBER; T.S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

902 ORAL Paclitaxel-carboplatin-gemcitab

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Sequential gemcitabine–carboplatin follo

✍ Johanna U. Mäenpää; Seija E. Grénman; Jyrki T. Jalkanen; Tapio A. Kuoppala; Arto 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

496 A phase II study of alternating pacl

✍ M. Adams; D. Mort; R. Coleman; L. Williams; A. Evans; M. Thompson 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Treatment of patients with advanced ovar

✍ W. Schröder; A. du Bois; W. Kuhn; H.J. Lück; V. Möbus; W. Meier; U. Nitz; S. Olb 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 149 KB